Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial
一项双盲、随机、对照的3b期临床试验，旨在评估mRNA新冠疫苗（RQ3013）在接种三剂灭活疫苗后作为第四剂加强针的安全性、免疫原性和有效性。
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102231
Liu, Xiaoqiang; Sun, Zhonghan; Wang, Zhongfang; Chen, Jingjing; Wu, Qianhui; Zheng, Yan; Yang, Xiaoyun; Mo, Luhui; Yan, Xuemei; Li, Wei; Zou, Yanxiang; Song, Huiling; Qian, Feng; Lu, Jing; Zhou, Hui; Wang, Yaping; Xiang, Zuoyun; Yu, Hongjie; Lin, Jinzhong; Yuan, Lin; Zheng, Yan
